Search

Search Results
Results 5541 - 5550 of 9447 for emergency medicine
  • Alodorm
    Drug - 2 Aug 2024
    Consumer Medicine Information (CMI) about Alodorm intended for persons living in Australia.
  • Pneumovax 23
    Drug - 30 Jul 2024
    Consumer Medicine Information (CMI) about Pneumovax 23 intended for persons living in Australia.
  • ZolaCos CP
    Drug - 30 Jul 2024
    Consumer Medicine Information (CMI) about ZolaCos CP intended for persons living in Australia.
  • Louisiana reclassifies drugs used in abortions as controlled dangerous substances
    News - 24 Jul 2024
    Louisiana lawmakers have added two drugs commonly used in pregnancy and reproductive health care to the state's list of controlled dangerous substances, a move that has alarmed doctors in the state.
  • Valganciclovir Viatris
    Drug - 19 Jul 2024
    Consumer Medicine Information (CMI) about Valganciclovir Viatris intended for persons living in Australia.
  • Ibilex
    Drug - 18 Jul 2024
    Consumer Medicine Information (CMI) about Ibilex intended for persons living in Australia.
  • Zavicefta
    Drug - 17 Jul 2024
    Consumer Medicine Information (CMI) about Zavicefta intended for persons living in Australia.
  • Aromasin
    Drug - 17 Jul 2024
    Consumer Medicine Information (CMI) about Aromasin intended for persons living in Australia.
  • New research aims to help lessen the risk of opioid misuse and overdose
    News - 15 Jul 2024
    New research aims to help reduce the quantity of unused prescription opioids after emergency department visits and lessen the risk of opioid misuse and overdose.
  • Varenicline Viatris
    Drug - 15 Jul 2024
    Consumer Medicine Information (CMI) about Varenicline Viatris intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback